Open Access

[Retracted] MicroRNA‑148a suppresses epithelial‑mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β‑catenin signaling pathway

  • Authors:
    • Long Peng
    • Zhanying Liu
    • Jian Xiao
    • Yi Tu
    • Zhen Wan
    • Haiwei Xiong
    • Yong Li
    • Weidong Xiao
  • View Affiliations

  • Published online on: February 6, 2023     https://doi.org/10.3892/or.2023.8493
  • Article Number: 56
  • Copyright : © Peng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

March-2023
Volume 49 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Peng L, Liu Z, Xiao J, Tu Y, Wan Z, Xiong H, Li Y and Xiao W: [Retracted] MicroRNA‑148a suppresses epithelial‑mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β‑catenin signaling pathway. Oncol Rep 49: 56, 2023
APA
Peng, L., Liu, Z., Xiao, J., Tu, Y., Wan, Z., Xiong, H. ... Xiao, W. (2023). [Retracted] MicroRNA‑148a suppresses epithelial‑mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β‑catenin signaling pathway. Oncology Reports, 49, 56. https://doi.org/10.3892/or.2023.8493
MLA
Peng, L., Liu, Z., Xiao, J., Tu, Y., Wan, Z., Xiong, H., Li, Y., Xiao, W."[Retracted] MicroRNA‑148a suppresses epithelial‑mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β‑catenin signaling pathway". Oncology Reports 49.3 (2023): 56.
Chicago
Peng, L., Liu, Z., Xiao, J., Tu, Y., Wan, Z., Xiong, H., Li, Y., Xiao, W."[Retracted] MicroRNA‑148a suppresses epithelial‑mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β‑catenin signaling pathway". Oncology Reports 49, no. 3 (2023): 56. https://doi.org/10.3892/or.2023.8493